Article info
PDFOriginal article
Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma
- Correspondence to Professor Dr Vladimir Jurišić, University of Kragujevac, Faculty of Medical Sciences, Svetozara Marković, 69, Kragujevac 34000, Serbia; vdvd{at}lycos.com
Citation
Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma
Publication history
- Received January 7, 2016
- Revised March 16, 2016
- Accepted March 22, 2016
- First published April 15, 2016.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/